Login to Your Account



A New Immunodeficiency Vaccine Twist?

Merck Conducting Human Safety Trials Of Anti-HIV T-Lymphocyte Killers; No Antibodies Need Apply

By David N. Leff


Thursday, January 17, 2002
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription